Search Within

Luis Alberto Diaz

Formats
  1. Journal Article (71)
  2. Meeting Abstract (58)
  3. Editorial (8)
  4. Review (7)
  5. Correspondence (5)
  6. Research Letter (5)
Groups
  1. Center for Pancreatic Cancer Research (154)
  2. Department of Medicine (154)
  3. Gastrointestinal Oncology Service (154)
  4. Solid Tumor Oncology Division (154)
  5. Survivorship Research (61)
  6. GSK Faculty (56)

More Groups

People
  1. Andrea Cercek Hanjis (43)
  2. Zsofia Stadler (38)
  3. Michael Berger (31)
  4. Benoit Rousseau (27)
  5. Rona Yaeger (26)
  6. Ahmet Zehir (24)

More People

Years
  1. 2025 (12)
  2. 2024 (13)
  3. 2023 (21)
  4. 2022 (16)
  5. 2021 (28)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Annals of Oncology (21)
  3. Cancer Discovery (8)
  4. Clinical Cancer Research (8)
  5. New England Journal of Medicine (7)
  6. Cancer Research (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (42)
  2. American Association for Cancer Research (27)
  3. Oxford University Press (23)
  4. Nature Publishing Group (12)
  5. Massachusetts Medical Society (7)
  6. Cell Press (6)

More Publishers

Results (154)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Immunopathologic stratification of colorectal cancer for checkpoint blockade immunotherapy
    Journal Article

    Llosa, N. J.; Luber, B.; Siegel, N.; Awan, A. H.; Oke, T.; Zhu, Q.; Bartlett, B. R.; Aulakh, L. K.; Thompson, E. D.; Jaffee, E. M.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors
    Journal Article

    Llosa, N. J.; Luber, B.; Tam, A. J.; Smith, K. N.; Siegel, N.; Awan, A. H.; Fan, H.; Oke, T.; Zhang, J.; Domingue, J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A summary of the Fight Colorectal Cancer working meeting: Exploring risk factors and etiology of sporadic early-age onset colorectal cancer
    Review

    Dwyer, A. J.; Murphy, C. C.; Boland, C. R.; Garcia, R.; Hampel, H.; Limburg, P.; Lowery, J.; Zauber, A. G.; Waring, S.; Worrall, S.; more...
    Gastroenterology (2019)

    Fulltext@MSK | Save
  • “Hey CIRI, what's my prognosis?”
    Editorial

    Wan, J. C. M.; White, J. R.; Diaz, L. A. Jr
    Cell (2019)

    Fulltext@MSK | Save
  • Immunotherapy in colorectal cancer: Rationale, challenges and potential
    Review

    Ganesh, K.; Stadler, Z. K.; Cercek, A.; Mendelsohn, R. B.; Shia, J.; Segal, N. H.; Diaz, L. A. Jr
    Nature Reviews Gastroenterology & Hepatology (2019)

    Fulltext@MSK | Save
  • Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response
    Journal Article

    Mandal, R.; Samstein, R. M.; Lee, K. W.; Havel, J. J.; Wang, H.; Krishna, C.; Sabio, E. Y.; Makarov, V.; Kuo, F.; Blecua, P.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Tumor genomic alterations in severe-combined immunodeficiency bare-lymphocyte syndrome genes are associated with high mutational burden and disproportional neo-antigen rates
    Journal Article

    Wang, Y.; Johnson, D. B.; Lu, S.; Diaz, L. A. Jr; Xu, Y.; Balko, J. M.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high
    Journal Article

    Middha, S.; Yaeger, R.; Shia, J.; Stadler, Z. K.; King, S.; Guercio, S.; Paroder, V.; Bates, D. D. B.; Rana, S.; Diaz, L. A. Jr; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save